StockData
Sigyn Therapeutics, Inc. logo

Sigyn Therapeutics, Inc. (SIGY) stock

SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $48.16KP/E –Yield –

Sigyn Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Sigyn Therapeutics's total assets was $135.57K at Sep 30, 2025. For fiscal 2024 it was $213.72K, down 33.6% from the year before. The highest annual figure on record is $2.07M in fiscal 2017.

Annual total assets

PeriodPeriod endValueChange
FY2024Dec 31, 2024$213.72K-33.6%
FY2023Dec 31, 2023$321.81K-3.3%
FY2022Dec 31, 2022$332.88K-53.1%
FY2021Dec 31, 2021$710.26K+2.3%
FY2020Dec 31, 2020$694.08K–
FY2019Dec 31, 2019$0-100.0%
FY2018Dec 31, 2018$862.05K-58.4%
FY2017Dec 31, 2017$2.07M+45.1%
FY2015Dec 31, 2015$1.43M+153.8%
FY2014Dec 31, 2014$562.27K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$135.57K-68.3%
Q2 FY2025Jun 30, 2025$51.76K-83.8%
Q1 FY2025Mar 31, 2025$244.31K-24.4%
Q4 FY2024Dec 31, 2024$213.72K-33.6%
Q3 FY2024Sep 30, 2024$427.44K+10.4%
Q2 FY2024Jun 30, 2024$320.17K-11.5%
Q1 FY2024Mar 31, 2024$323.30K-51.0%
Q4 FY2023Dec 31, 2023$321.81K-3.3%
Q3 FY2023Sep 30, 2023$387.22K+6.9%
Q2 FY2023Jun 30, 2023$361.82K-8.6%
Q1 FY2023Mar 31, 2023$660.45K+47.6%
Q4 FY2022Dec 31, 2022$332.88K-53.1%
Q3 FY2022Sep 30, 2022$362.27K-74.9%
Q2 FY2022Jun 30, 2022$395.91K-80.1%
Q1 FY2022Mar 31, 2022$447.41K-26.5%
Q4 FY2021Dec 31, 2021$710.26K+2.3%
Q3 FY2021Sep 30, 2021$1.44M+136.1%
Q2 FY2021Jun 30, 2021$1.99M+220.0%
Q1 FY2021Mar 31, 2021$608.96K-3.9%
Q4 FY2020Dec 31, 2020$694.08K–
Q3 FY2020Sep 30, 2020$610.18K-20.0%
Q2 FY2020Jun 30, 2020$622.69K-22.1%
Q1 FY2020Mar 31, 2020$633.58K-23.3%
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$763.15K-59.1%
Q2 FY2019Jun 30, 2019$798.84K-58.7%
Q1 FY2019Mar 31, 2019$826.00K-59.6%
Q4 FY2018Dec 31, 2018$862.05K-58.4%
Q3 FY2018Sep 30, 2018$1.87M+76.4%
Q2 FY2018Jun 30, 2018$1.93M+66.9%
Q1 FY2018Mar 31, 2018$2.05M+58.0%
Q4 FY2017Dec 31, 2017$2.07M+45.1%
Q3 FY2016Sep 30, 2016$1.06M–
Q2 FY2016Jun 30, 2016$1.16M–
Q1 FY2016Mar 31, 2016$1.29M–
Q4 FY2015Dec 31, 2015$1.43M–

More Sigyn Therapeutics figures

See a number that looks wrong?